Traversa Therapeutics has appointed Barry Toyonaga to the position of senior vice president of business development.
Toyonaga will be responsible for the development and execution of global strategic partnering related to human therapeutics and high-throughput screening, the company said.
He previously held various positions for Johnson & Johnson, as well as its corporate venture arm, Traversa said. He has also worked in academia at institutions such as the Scripps Research Institute and the California Institute of Technology. He holds a PhD in organic chemistry from the University of Toronto.